Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pemedolac (Dexpemedolac)是一种小分子 COX 抑制剂,可作为一种新型长效非麻醉性镇痛化合物,可用于治疗神经系统疾病、皮肤和肌肉骨骼疾病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 600 | 现货 | ||
5 mg | ¥ 1,430 | 现货 | ||
10 mg | ¥ 2,130 | 现货 | ||
25 mg | ¥ 3,620 | 现货 | ||
50 mg | ¥ 5,220 | 现货 | ||
100 mg | ¥ 7,380 | 现货 | ||
500 mg | ¥ 14,700 | 现货 |
产品描述 | Pemedolac (Dexpemedolac) is a small molecule COX inhibitor used to treat neurological disorders, skin and musculoskeletal disorders. |
体内活性 | Pemedolac exhibited potent analgesic effects against chemically induced pain in rats and mice and against inflammatory pain in rats. In each of the animal models used the analgesic potency of pemedolac was defined by an ED50 of 2.0 mg/kg p.o. or less. Significant analgesic activity was detected in rats at 16 hr after administration of 1 mg/kg p.o. (paw pressure test) and at 10 hr after administration of 10 mg/kg p.o. to mice (p-phenylbenzoquinone writhing). Inasmuch as pemedolac was inactive in the hot plate and tail-flick tests; and its analgesic activity was not antagonized by naloxone (1 mg/kg s.c.), and tolerance did not develop upon multiple administrations; this drug does not exert its analgesic effects through an opiate mechanism. Pemedolac differed from standard nonsteroidal anti-inflammatory drugs (NSAIDs) in that the doses that produced analgesia were much lower than those required for either anti-inflammatory or gastric irritant effects. In acute anti-inflammatory tests, pemedolac exhibited only weak activity as evidenced by an ED50 of approximately 100 mg/kg p.o. in the carrageenan paw edema procedure. This demonstrates for pemedolac a separation of at least 50-fold between the acute analgesic and anti-inflammatory activities, which was greater than that observed with reference NSAIDs.[1] |
别名 | Dexpemedolac |
分子量 | 349.42 |
分子式 | C22H23NO3 |
CAS No. | 114716-16-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (143.09 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.8619 mL | 14.3094 mL | 28.6189 mL | 71.5471 mL |
5 mM | 0.5724 mL | 2.8619 mL | 5.7238 mL | 14.3094 mL | |
10 mM | 0.2862 mL | 1.4309 mL | 2.8619 mL | 7.1547 mL | |
20 mM | 0.1431 mL | 0.7155 mL | 1.4309 mL | 3.5774 mL | |
50 mM | 0.0572 mL | 0.2862 mL | 0.5724 mL | 1.4309 mL | |
100 mM | 0.0286 mL | 0.1431 mL | 0.2862 mL | 0.7155 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Pemedolac 114716-16-4 Immunology/Inflammation Neuroscience COX Dexpemedolac Inhibitor inhibitor inhibit